| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/CJN.2018.353 |
| P698 | PubMed publication ID | 30688198 |
| P2093 | author name string | Donald F Weaver | |
| Prachi Vilekar | |||
| S Imindu Liyanage | |||
| P2860 | cites work | Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation | Q22008492 |
| Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease | Q22248076 | ||
| Diet and Alzheimer’s disease | Q22252600 | ||
| Apolipoprotein E and Alzheimer disease | Q24563061 | ||
| Dietary folate and vitamins B-12 and B-6 not associated with incident Alzheimer's disease | Q24625922 | ||
| Brain foods: the effects of nutrients on brain function | Q24647109 | ||
| Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau | Q24651880 | ||
| Adherence to Mediterranean diet and health status: meta-analysis | Q24652259 | ||
| Gut Microbiota: The Brain Peacekeeper | Q26751052 | ||
| Impact of the gut microbiota on inflammation, obesity, and metabolic disease | Q26751430 | ||
| Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease | Q26773657 | ||
| Role of the normal gut microbiota | Q26798294 | ||
| Components of a Mediterranean diet and their impact on cognitive functions in aging | Q26798765 | ||
| Gut/brain axis and the microbiota | Q26998106 | ||
| Neurodegenerative diseases: expanding the prion concept | Q27011744 | ||
| Damaging effects of a high-fat diet to the brain and cognition: a review of proposed mechanisms | Q27023109 | ||
| Obese-type gut microbiota induce neurobehavioral changes in the absence of obesity | Q27329095 | ||
| Hippocampal neurogenesis as a target for the treatment of mental illness: a critical evaluation | Q27687034 | ||
| Targeting neuroinflammation in Alzheimer's disease | Q28078474 | ||
| Insulin, aging, and the brain: mechanisms and implications | Q28081455 | ||
| Alzheimer's disease and type 2 diabetes via chronic inflammatory mechanisms | Q28086892 | ||
| Cellular functions of the amyloid precursor protein from development to dementia | Q28087171 | ||
| Inflammation and Alzheimer's disease | Q28138617 | ||
| Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour | Q29617115 | ||
| Using Multicountry Ecological and Observational Studies to Determine Dietary Risk Factors for Alzheimer's Disease | Q30248800 | ||
| Glucose levels and risk of dementia | Q30574095 | ||
| Neuropathology of Alzheimer's disease | Q33526568 | ||
| Cholesterol Perturbation in Mice Results in p53 Degradation and Axonal Pathology through p38 MAPK and Mdm2 Activation | Q33553179 | ||
| Omega-3 fatty acids and dementia. | Q33602402 | ||
| Copper in Alzheimer's disease: too much or too little? | Q37464172 | ||
| Zinc and the aging brain | Q37496663 | ||
| Genetics of Alzheimer's disease in Caribbean Hispanic and African American populations | Q37515666 | ||
| Dietary fats, cerebrovasculature integrity and Alzheimer's disease risk | Q37629069 | ||
| Alzheimer's disease and the amyloid-beta peptide | Q37671455 | ||
| Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline | Q37678546 | ||
| Insulin receptor signaling in the development of neuronal structure and function. | Q37709539 | ||
| Brain insulin signaling: a key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes | Q37930196 | ||
| The effects of long-term omega-3 fatty acid supplementation on cognition and Alzheimer's pathology in animal models of Alzheimer's disease: a systematic review and meta-analysis. | Q37946300 | ||
| Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature | Q37982377 | ||
| Metabolomics view on gut microbiome modulation by polyphenol-rich foods. | Q38035928 | ||
| Omega-3 fatty acids: benefits for cardio-cerebro-vascular diseases | Q38048953 | ||
| Vitamin B12 intake and status and cognitive function in elderly people. | Q38065812 | ||
| Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease - challenges and perspectives | Q38147438 | ||
| Mediterranean diet and cardiovascular risk factors: a systematic review. | Q38164803 | ||
| Dietary patterns, Mediterranean diet, and cardiovascular disease | Q38174015 | ||
| Insulin dysfunction and Tau pathology. | Q38191590 | ||
| Lipid metabolism in Alzheimer's disease | Q38204719 | ||
| Low-copper diet as a preventive strategy for Alzheimer's disease. | Q38218984 | ||
| Diet quality is associated with better cognitive test performance among aging men and women | Q37348356 | ||
| Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer's mouse model | Q37436099 | ||
| Effects of diet on brain plasticity in animal and human studies: mind the gap. | Q33679165 | ||
| Behavioural symptoms in patients with Alzheimer's disease and their association with cognitive impairment | Q33709765 | ||
| Survival in Alzheimer disease: a multiethnic, population-based study of incident cases | Q33745430 | ||
| Alzheimer's disease drug-development pipeline: few candidates, frequent failures | Q33892815 | ||
| Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis | Q33904779 | ||
| Thiamine for Alzheimer's disease | Q33909265 | ||
| Alzheimer's disease, beta-amyloid protein and zinc | Q33913084 | ||
| Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana | Q33933341 | ||
| Plasma homocysteine as a risk factor for dementia and Alzheimer's disease | Q33957399 | ||
| Dietary fats and the risk of incident Alzheimer disease | Q33964261 | ||
| Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease | Q33967270 | ||
| Zinc ions promote Alzheimer Abeta aggregation via population shift of polymorphic states | Q34006345 | ||
| Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk | Q34017726 | ||
| Food combination and Alzheimer disease risk: a protective diet | Q34022031 | ||
| Trends in diet and Alzheimer's disease during the nutrition transition in Japan and developing countries | Q34038148 | ||
| Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study | Q34063247 | ||
| Dietary assessment methods in epidemiologic studies | Q34132160 | ||
| Effects of ω-3 fatty acids on cognitive performance: a meta-analysis | Q34150618 | ||
| Detrimental effects of arachidonic acid and its metabolites in cellular and mouse models of Alzheimer's disease: structural insight | Q34216658 | ||
| Fatty acid status and its relationship to cognitive decline and homocysteine levels in the elderly | Q34263507 | ||
| Effects of the dietary approaches to stop hypertension diet, exercise, and caloric restriction on neurocognition in overweight adults with high blood pressure | Q34281743 | ||
| Abnormal thiamine-dependent processes in Alzheimer's Disease. Lessons from diabetes | Q34299928 | ||
| Gut-brain axis: how the microbiome influences anxiety and depression | Q34326411 | ||
| Psychiatric phenomena in Alzheimer's disease. IV: Disorders of behaviour | Q34366401 | ||
| The 32-year relationship between cholesterol and dementia from midlife to late life | Q34370050 | ||
| Impaired satiation and increased feeding behaviour in the triple-transgenic Alzheimer's disease mouse model. | Q34440887 | ||
| Memantine reduces consumption of highly palatable food in a rat model of binge eating | Q34486676 | ||
| Mediterranean diet and risk for Alzheimer's disease | Q34508496 | ||
| Mediterranean diet, Alzheimer disease, and vascular mediation | Q34510165 | ||
| A 24-week, randomized, controlled trial of rivastigmine patch 13.3 mg/24 h versus 4.6 mg/24 h in severe Alzheimer's dementia | Q34521949 | ||
| Dietary niacin and the risk of incident Alzheimer's disease and of cognitive decline | Q34549383 | ||
| An overview of biomarkers in Alzheimer's disease | Q34574944 | ||
| Mediterranean diet and Alzheimer disease mortality | Q34582840 | ||
| Diabetes mellitus and Alzheimer's disease: shared pathology and treatment? | Q34608998 | ||
| Serum zinc, senile plaques, and neurofibrillary tangles: findings from the Nun Study. | Q51584614 | ||
| Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. | Q53218504 | ||
| Behavioural disturbances in psychiatric inpatients with dementia of the Alzheimer's type in Taiwan. | Q53219434 | ||
| Marked hyperphagia associated with total loss of satiety in Alzheimer's disease. | Q53294075 | ||
| Efficacy of increasing donepezil in mild to moderate Alzheimer's disease patients who show a diminished response to 5 mg donepezil: a preliminary study. | Q53342483 | ||
| Similarities and differences between Alzheimer's disease and vascular dementia from the viewpoint of nutrition. | Q53356043 | ||
| Protein and thiamin intakes are not related to cognitive function in well-nourished community-living older adults | Q61679910 | ||
| Effect of dietary fat on the pharmacokinetics and pharmacodynamics of cyclosporine in kidney transplant recipients | Q72146673 | ||
| Drug metabolism in malnutrition and obesity: clinical concerns | Q72553680 | ||
| Eating Behaviors and Dietary Changes in Patients With Dementia | Q88582862 | ||
| High-sugar diets, type 2 diabetes and Alzheimer's disease | Q34651637 | ||
| Tau in Alzheimer disease and related tauopathies | Q34953869 | ||
| Zinc binding directly regulates tau toxicity independent of tau hyperphosphorylation | Q35012356 | ||
| Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics | Q35114057 | ||
| High levels of homocysteine results in cerebral amyloid angiopathy in mice | Q35185043 | ||
| Homocysteine exacerbates β-amyloid pathology, tau pathology, and cognitive deficit in a mouse model of Alzheimer disease with plaques and tangles | Q35185115 | ||
| Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer's disease | Q35469584 | ||
| Control of brain development, function, and behavior by the microbiome | Q35631733 | ||
| Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations | Q35642416 | ||
| Gut microbiota and inflammation | Q35670894 | ||
| Thiamine deficiency induces endoplasmic reticulum stress in neurons. | Q35674936 | ||
| Molecular bases of the treatment of Alzheimer's disease with antioxidants: prevention of oxidative stress | Q35722476 | ||
| Relationship between eating disturbance and dementia severity in patients with Alzheimer's disease | Q35743549 | ||
| Nutrient intake and plasma β-amyloid. | Q36014708 | ||
| Why do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices? | Q36022784 | ||
| Mechanisms of regulation of gene expression by fatty acids | Q36052468 | ||
| Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype | Q36457368 | ||
| Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia | Q36477209 | ||
| GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration | Q36526013 | ||
| Regulation of drug metabolism and disposition during inflammation and infection | Q36544874 | ||
| Adherence to a Mediterranean diet and Alzheimer's disease risk in an Australian population. | Q36591390 | ||
| Effects of gut microbes on nutrient absorption and energy regulation | Q36694958 | ||
| Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment | Q36789901 | ||
| Dietary folate, vitamin B-12, vitamin B-6 and incident Alzheimer's disease: the cache county memory, health and aging study | Q36822633 | ||
| The role of vitamins and minerals in energy metabolism and well-being | Q36861425 | ||
| Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures | Q36866566 | ||
| Cholesterol Biosynthesis Supports Myelin Gene Expression and Axon Ensheathment through Modulation of P13K/Akt/mTor Signaling. | Q37110581 | ||
| Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease | Q37141206 | ||
| Dietary patterns associated with Alzheimer's disease: population based study | Q37189725 | ||
| Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship | Q37218110 | ||
| Metabolic and structural role of thiamine in nervous tissues. | Q37222354 | ||
| Cholesterol retention in Alzheimer's brain is responsible for high beta- and gamma-secretase activities and Abeta production | Q37288781 | ||
| Early Statin Use and the Progression of Alzheimer Disease: A Total Population-Based Case-Control Study | Q37328707 | ||
| Interaction of Alzheimer's β-amyloid peptides with cholesterol: mechanistic insights into amyloid pore formation | Q38226890 | ||
| Zinc in Alzheimer's Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies | Q38362089 | ||
| Diet, nutrients and metabolism: cogs in the wheel driving Alzheimer's disease pathology? | Q38413096 | ||
| Review of the advances in treatment for Alzheimer disease: Strategies for combating β-amyloid protein | Q38481869 | ||
| Effects of thiamine deficiency on brain metabolism: implications for the pathogenesis of the Wernicke-Korsakoff syndrome | Q38693828 | ||
| Drug metabolism and pharmacokinetics in malnourished children | Q38756087 | ||
| Inhibition of Cholesterol Biosynthesis Reduces γ-Secretase Activity and Amyloid-β Generation | Q38790457 | ||
| Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease | Q38828830 | ||
| Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease. | Q38955990 | ||
| Glucose Transporters in Brain: In Health and in Alzheimer's Disease | Q39012005 | ||
| Thiamine deficiency increases β-secretase activity and accumulation of β-amyloid peptides | Q39881205 | ||
| Nutritional Status of Patients with Alzheimer's Disease and Their Caregivers. | Q40405470 | ||
| Alzheimer's Disease in the Danish Malnutrition Period 1999-2007. | Q40457876 | ||
| Cholesterol-dependent formation of GM1 ganglioside-bound amyloid beta-protein, an endogenous seed for Alzheimer amyloid | Q40807391 | ||
| Influence of diet and nutritional status on drug metabolism | Q41128208 | ||
| Dietary preference for sweet foods in patients with dementia | Q41206563 | ||
| Omega-3 fatty acids correlate with gut microbiome diversity and production of N-carbamylglutamate in middle aged and elderly women. | Q41321862 | ||
| High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice. | Q41881815 | ||
| Microbiota modulation counteracts Alzheimer's disease progression influencing neuronal proteolysis and gut hormones plasma levels. | Q42098016 | ||
| Influence of dietary fat on the lipid composition of rat brain synaptosomal and microsomal membranes | Q42126218 | ||
| Sugar and Alzheimer's disease: a bittersweet truth | Q42698401 | ||
| A serotoninergic basis for hyperphagic eating changes in Alzheimer's disease | Q43264302 | ||
| Vitamin B(12) and folate in relation to the development of Alzheimer's disease | Q43600976 | ||
| Nutrition and cognitive deficit in the elderly: a population study | Q43848156 | ||
| Souvenaid®: a new approach to management of early Alzheimer's disease | Q43864462 | ||
| Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study | Q43935519 | ||
| Diet and risk of dementia: Does fat matter?: The Rotterdam Study | Q44260511 | ||
| High-fat meals increase the clearance of cyclosporine | Q44515223 | ||
| Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study | Q44734509 | ||
| Copper binding to the amyloid-beta (Abeta) peptide associated with Alzheimer's disease: folding, coordination geometry, pH dependence, stoichiometry, and affinity of Abeta-(1-28): insights from a range of complementary spectroscopic techniques | Q44772732 | ||
| The interplay between oxidative stress and brain-derived neurotrophic factor modulates the outcome of a saturated fat diet on synaptic plasticity and cognition | Q44840038 | ||
| 24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial | Q46105528 | ||
| Copper and Alzheimer's Disease | Q46309586 | ||
| Omega-3 fatty acids increase the unfolded protein response and improve amyloid-β phagocytosis by macrophages of patients with mild cognitive impairment | Q46579757 | ||
| High prevalence of metabolic syndrome among men in Okinawa | Q46736131 | ||
| Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms. | Q46852229 | ||
| Association between malnutrition and hyperhomocysteine in Alzheimer's disease patients and diet intervention of betaine. | Q47678558 | ||
| Evidence for widespread, severe brain copper deficiency in Alzheimer's dementia. | Q47683018 | ||
| Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study | Q47806690 | ||
| Malnutrition is associated with dementia severity and geriatric syndromes in patients with Alzheimer disease | Q47901871 | ||
| Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type? | Q48130941 | ||
| Arachidonic acid diet attenuates brain Aβ deposition in Tg2576 mice | Q48226363 | ||
| Etiology and pathogenesis of Alzheimer's disease. | Q48354515 | ||
| A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice | Q48381797 | ||
| Plasma thiamine deficiency associated with Alzheimer's disease but not Parkinson's disease | Q48478955 | ||
| Caloric intake and the risk of Alzheimer disease | Q48520005 | ||
| Differential effect of arachidonic acid and docosahexaenoic acid on age-related decreases in hippocampal neurogenesis. | Q48589627 | ||
| High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model | Q48877805 | ||
| Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan | Q49102378 | ||
| Mood and cognitive performance effects of isocaloric lunches differing in fat and carbohydrate content. | Q51132733 | ||
| P433 | issue | 1 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 23-34 | |
| P577 | publication date | 2019-01-01 | |
| P1433 | published in | Canadian Journal of Neurological Sciences | Q5030246 |
| P1476 | title | Nutrients in Alzheimer's Disease: The Interaction of Diet, Drugs and Disease | |
| P478 | volume | 46 |
Search more.